专利检索 ap:("Betta Pharmaceuticals Co., Ltd") AND inv:"WANG, Yang" 第 1 页

1.

发明公开
USE OF ENSARTINIB OR SALT THEREOF IN TREATMENT OF DISEASE CARRYING MET 14 EXON SKIPPING MUTATION 审中-实审

公开(公告)号：EP4385510A1

公开(公告)日：2024-06-19

申请号：EP22855304.6

申请日：2022-08-04

申请人： Betta Pharmaceuticals Co., Ltd

发明人： LIU, Lijia , GUO, Jing , WANG, Yu , ZHAO, Xiangdong , CHEN, Jie , WANG, Yang , YUAN, Xiaobin , JI, Dong , KONG, Licheng , DING, Lieming

IPC分类号： A61K31/501 , A61P35/00

CPC分类号： A61K31/501 , A61P35/00

摘要： Embodiments of the present application provide Ensartinib or a salt thereof and a use of a composition containing Ensartinib or the salt thereof in treatment of a disease carrying MET 14 exon skipping mutation.